Thursday, October 25
9:00 - 3:30 p.m.

Armenise building
D-Amphitheater 125
210 Longwood Avenue

What is the event?
A one-day conference on innovative approaches to collecting and sharing clinical data, and the implications of these approaches for validating clinical biomarkers.

Why is this important?
Biomarkers have potential to transform drug development and clinical practice. However, the number of validated biomarkers, whose properties and utility are well-understood, remains relatively few. New scientific and regulatory approaches are thus needed to generate or capture the data necessary to validate biomarkers and ensure their safe and reliable use.

Why do you need to be here?
Our lineup includes leadership from both public and private organizations who are at the cutting edge of clinical data science. Come hear about these exciting initiatives, how they may be able to deliver on the promise of biomarkers, and then engage with us in a discussion of the ethical challenges and opportunities.

This event is free and open to the public, please register here.